AnalystsChristopher LiuChristopher Liu's Stock Forecasts
AnalystsChristopher Liu
Sectors:
Industries:
Analyst Ranking
Top 33%
#1699 out of 5116 analysts
Average Return
+51.82%
Win Rate
83%5 out of 6
Risk vs Reward
Poor
Good
Christopher Liu's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Lyell Immunopharma IncLYEL | +87.06% | $12.83 | $24.00 | 2025-09-26 - 2025-11-28 | Strong Buy |
Relay Therapeutics IncRLAY | +80.41% | $4.39 | $7.92 | 2024-12-04 - 2025-11-28 | Buy |
Ideaya Biosciences IncIDYA | +65.71% | $21.64 | $35.86 | 2023-08-08 - 2024-08-07 | Buy |
Genelux CorpGNLX | +58.40% | $3.51 | $5.56 | 2025-07-21 - 2025-11-28 | Strong Buy |
Exelixis IncEXEL | +22.25% | $36.13 | $44.17 | 2025-10-21 - 2025-11-28 | Buy |
Christopher Liu Analyst Color
Get additional color on Christopher Liu's coverage of popular stocks
Christopher Liu's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Exelixis IncEXEL | 2 | Buy | $48.00 | +8.67% | Upgrades | a month ago |
Lyell Immunopharma IncLYEL | 1 | Strong Buy | $20.00 | -16.67% | Initiates Coverage On | 2 months ago |
Adagene IncADAG | 1 | Strong Buy | $9.00 | +347.76% | Initiates Coverage On | 2 months ago |
Genelux CorpGNLX | 1 | Strong Buy | $10.00 | +79.86% | Initiates Coverage On | 4 months ago |
Relay Therapeutics IncRLAY | 1 | Buy | $18.00 | +127.27% | Maintains | a year ago |
Ideaya Biosciences IncIDYA | 2 | Hold | $27.00 | N/A | Downgrades | a year ago |
Nuvalent IncNUVL | 1 | Hold | $42.00 | N/A | Initiates Coverage On | 2 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.